Stock listing

A0LGJ2 Stock Price, News, Filings & Events — Genfit Sa

Selected listing: A0LGJ2 · LSX · EUR · DE

A0LGJ2:LSX is the public stock listing for Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic diseases and liver conditions. The company is actively engaged in clinical trials and research to advance its pipeline of drug candidates. Recent news includes updates on their ongoing studies and regulatory filings, which are crucial for their growth strategy. Investors can find relevant financial filings and upcoming events that may impact the stock's performance on this page.

A0LGJ2:LSXEURDEUpdated July 24, 2026
Genfit Sa logo
Ticker
A0LGJ2:LSX
Asset type
Stock
Market cap
$757.2M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Genfit Sa A0LGJ2:LSX stock context

A0LGJ2:LSX is the public stock listing for Genfit Sa, a biopharmaceutical company focused on developing innovative therapies for metabolic diseases and liver conditions. The company is actively engaged in clinical trials and research to advance its pipeline of drug candidates. Recent news includes updates on their ongoing studies and regulatory filings, which are crucial for their growth strategy. Investors can find relevant financial filings and upcoming events that may impact the stock's performance on this page.

Research Genfit Sa

Alternate listings